Speakers

Please bookmark this page to stay up to date with all confirmed speakers.

Mr Ali Albasri, University of Oxford, UK

Ali is a clinical pharmacist and researcher at the University of Oxford. His work focusses on the role of pharmacists in the management of hypertension. His research has led to the production of a ‘toolkit’ for pharmacists, aiding their delivery of hypertension management services. In 2017 he was awarded the Allied Health Professional award by the BIHS.
Dr Guy Bewick, University of Aberdeen, UK

My group studies how nerve terminal sensitivity and function is modulated in model systems, using and developing a variety of techniques to do so. We discovered that stretch-sensitive nerve terminals, including baroreceptors, have a powerful self-regulating secretory system. Recent work indicates its unique pharmacology offers a promising novel drug target for treating hypertension.
Dr Jeff Breckon, Sheffield Hallam University, UK

Dr Jeff Breckon is Head of the AWRC Behaviour Change Research Group at Sheffield Hallam University. He is a BPS and HCPC Chartered Psychologist and a member of MINT (Motivational Interviewing Network of Trainers) and BPS (British Psychological Association).
Professor Alistair Burns, University of Manchester, UK

Alistair Burns is Professor of Old Age Psychiatry at The University of Manchester and an Honorary Consultant Old Age Psychiatrist in the Greater Manchester Mental Health NHS Foundation Trust. He is the National Clinical Director for Dementia and Older People’s Mental Health at NHS England and NHS Improvement.

He was made an honorary fellow of the Royal College of Psychiatrists in 2016, received the lifetime achievement award from their old age Faculty in 2015 and was awarded the CBE in 2016 for contributions to health and social care, in particular dementia.
Dr Constantina Chrysochou, Salford Royal NHS Foundation Trust, UK

Consultant Nephrologist at Salford Royal NHS Foundation Trust and Honorary Lecturer at the University of Manchester.

Department lead for Young Adult Transition Medicine and Inpatient governance. Clinical commitments include glomerulonephritis, renovascular disease and dialysis. Research interests are in atheromatous renovascular disease, fibromuscular dysplasia (national RADAR lead for FMD) and nephrogenic systemic fibrosis. Tina is the Trust’s Freedom to Speak up Guardian and President Elect for the Royal Society of Medicine Nephrology section.
Dr Chris Clark, University of Exeter, UK

Senior Partner in the Mid Devon Medical Practice, I have developed and lead research groups examining the organisation and delivery of hypertension care and the detection and management of postural hypotension. I have a long-standing interest in inter-arm blood pressure difference and lead the international INTERPRESS collaboration, examining aetiology and mortality implications of an inter-arm difference.
Professor Sir Rory Collins, University of Oxford, UK

Rory Collins studied Medicine at St Thomas’s Hospital Medical School, London, and Statistics at George Washington University and Oxford University.

He came to Oxford in 1981 to run the ISIS “mega-trials” which showed that emergency treatment of heart attacks with streptokinase and aspirin halves mortality. Subsequently, his focus has involved showing that lowering LDL-cholesterol safely reduces the risk of having heart attacks and strokes.

Rory became Principal Investigator of the UK Biobank prospective study of 500,000 people in 2005. He was elected to the Fellowship of the UK Academy of Medical Science in 2004 and the Royal Society in 2015, and knighted by the Queen for services to Science in 2011.
Dr David Kernick, Exeter, UK

General Practitioner with a special interest in Headache.
Professor Una Martin, University of Birmingham, UK

Una Martin is Deputy Pro-Vice Chancellor and Professor of Clinical Pharmacology at the University of Birmingham. She leads the Hypertension Service at University Hospital Birmingham. Research outputs have included the influence of ethnicity on blood pressure measurement, the relationship of inter-arm blood pressure measurements to ambulatory readings and the difficulty of treating elderly patients to target because of adverse drug reactions.
Professor Neil Poulter, Imperial College London, UK

Neil Poulter is Professor of Preventive Cardiovascular Medicine at Imperial College London where he is Director of the Imperial Clinical Trials Unit. He is an Honorary Consultant Physician and Epidemiologist at the Hammersmith Hospital, a past president of the BHS and is currently the President of ISH.